Carestream Health and Caliper Life Sciences have settled their lawsuits by agreeing to dismiss their respective claims and counterclaims.
In the first lawsuit, filed in February 2010, Caliper and its wholly owned subsidiary, Xenogen, along with Stanford University, alleged that Carestream's marketing and sales of its instrument systems induced infringement of seven imaging patents that are exclusively licensed to Xenogen by Stanford University.
In the second lawsuit, filed in July 2010, Carestream alleged that Caliper's Lumina XR system infringed upon a Carestream imaging patent.
Under the agreement, Carestream agreed not to market and sell in-vivo optical imaging systems for certain applications covered by patents licensed from Stanford by Xenogen and Caliper. Carestream also will not assert that the Lumina XR system as currently configured and sold by Caliper infringes upon any of Carestream's patents.
